Education
About Us
Working with TipRanks
Follow Us
Georgia Erbez Insider Profile
11 Followers
Georgia Erbez, Exec VP & CFO at Asterias Biotherapeutics, holds 0.00 shares in Asterias Biotherapeutics (Ticker: AST), holds ― shares in Zosano Pharma (Ticker: ZSANQ), holds ― shares in Artelo Biosciences (Ticker: ARTL). Most recently, Georgia Erbez ― shares of Asterias Biotherapeutics on ― for an estimated value of ―.
Georgia Erbez Asterias Biotherapeutics (AST)Exec VP & CFO
Asterias Biotherapeutics (AST)
Exec VP & CFO
Ranked #81,797 out of 106,324 Corporate Insiders
Profitable Transactions
4 out of 9 Profitable Transactions
Average Return
-13.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Georgia Erbez holds in companies
Most Profitable Insider Trade
The most profitable trade made by Georgia Erbez
Georgia Erbez's Trading History
Asterias Biotherapeutics
―
―
―
$0.00
Zosano Pharma
May 25, 2017
―
Informative Buy
89.76K
―
Artelo Biosciences
―
Director
―
―
Harpoon Therapeutics
Sep 22, 2021
―
Informative Buy
83.43K
$2.26M
Sierra Oncology
―
―
―
―
Coherus Biosciences
―
Director
―
―
Codexis
Feb 09, 2026
CFO and Chief Business Officer
Informative Sell
4.97K
$82.84K
Raptor Pharmaceutical Corp.
May 15, 2014
―
Informative Buy
127.19K
$176.40K
List of latest transactions for each holding click on a transaction to see Georgia Erbez's performance on stock
You May Also Like
Georgia Erbez insider profile FAQ
What is the percentage of profitable transactions made by Georgia Erbez?
The percentage of profitable transactions made by Georgia Erbez is 44%.
What is the average return per transaction made by Georgia Erbez?
The average return per transaction made by Georgia Erbez is -13.00%.
What stocks does Georgia Erbez hold?
Georgia Erbez holds: AST, ZSANQ, ARTL, HARP, SRRA, CHRS, CDXS, RPTP stocks.
What was Georgia Erbez’s latest transaction?
Georgia Erbez latest transaction was an Uninformative Buy of ―.
What was Georgia Erbez's most profitable transaction?
Georgia Erbez’s most profitable transaction was an Informative Sell of CDXS stock on October 15, 2025. The return on the trade was 55.10%.
What is Georgia Erbez's role in Asterias Biotherapeutics?
Georgia Erbez's role in Asterias Biotherapeutics is Exec VP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.